Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.
Your search for major depressive disorder returned 15 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.
Patients with MDD were randomly assigned in a 1:1:1 ratio to receive 1.5 mg daily cariprazine, 3.0 mg daily cariprazine, or placebo for 6 weeks.
The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.
Investigators sought to assess associations for US Army soldiers bullied by fellow soldiers with mental health outcomes.
Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.
Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.
Investigators designed this study to evaluate the feasibility and potential utility of a peer-led CBT-based workshop for PPD.
Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.
Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.
Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.
The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.
Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.
Investigators aimed to evaluate the efficacy of combined treatment (antidepressants plus STPP) vs antidepressants (with or without brief supportive psychotherapy) on depressive symptoms in adults in acute-phase depression.
Can reducing RNT with psychological treatment approaches help improve youth depression and anxiety?
Latest News Your top articles for SundayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses